TREX BIO, INC- INTENDS TO USE ABOUT $90 MLN OF IPO PROCEEDS TO ADVANCE CLINICAL DEVELOPMENT OF TRB-061, INCLUDING TO FUND PHASE 2 TRIALS

Reuters · 2d ago

Please log in to view news